Vofatamab

Tax included
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC).
MedChemExpress 
HY-P99384

Data sheet

Size
Multiple sizes
Reactivity
FGFR
Application
Cancer-Kinase/protease
CAS
1312305-12-6